Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

As Space Traffic Increases, Rockets Pose a Growing Risk to Airplanes

Planes risk serious damage from rocket debris, but politicians can pressure space organizations to take action.

Inverse

'I have 'Jolie gene' and petrified my cancer will return - new NHS drug gives me future'

Claire Spragg was diagnosed with triple negative breast cancer and discovered she carried the faulty BRCA2 gene. She was able to take a year's supply of olaparib, which is now available on the NHS

Daily Mirror

Husband of North East radio presenter who died after AstraZeneca Covid-19 vaccine taking legal action

Lisa Shaw, 44, who worked for BBC Radio Newcastle, died a week after her first jab

Chronicle Live

From analysis to the latest developments in health,
read the most diverse news in one place.

Cancer patients to receive ‘life-changing’ AstraZeneca drug through NHS

Clinical trials have shown the drug could extend advanced prostate cancer patients’ lives by an average of six months, NHS England said

The Independent UK

Airplanes face a growing risk of being hit by uncontrolled re-entries of rockets used to launch satellites

On May 11, 2020 a deadly threat flew from Los Angeles to New York City in under nine minutes. It was a 20-tonne Chinese Long March 5B rocket body passing around 60 miles overhead.

The Conversation

Jeremy Hunt aims to spur business investment with ‘full expensing’ tax break

Measure over next three years will allow firms to write off costs of IT equipment and machinery against tax on profits

The Guardian - UK

Thousands still waiting for Covid jab payout as over £5million paid in damages so far

Under the Vaccine Damage Payment Scheme, those harmed by the coronavirus jab get a £120,000 payment but thousands are still waiting for their claims to be assessed

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

The Best Stock to Buy for Under $100 Right Now

Strong fundamentals and bright prospects of AstraZeneca (AZN), trading below $100 a share, could help investors secure decent risk-adjusted returns on their investments in a choppy market environment. Read on….

StockNews.com

Rishi Sunak faces Tory Budget rebellion over corporation tax REDIRECTED

Leaders of Tory several factions write to PM urging rethink

The Independent UK

Kwasi Kwarteng STILL supports 'general direction' of his economy-destroying mini budget

Former Chancellor of the Exchequer Kwasi Kwarteng is sticking by the "general direction" of his mini budget that crashed the UK economy, but admits that he has regrets

Daily Mirror

RMT strikes to continue, says Mick Lynch, after members reject ‘dreadful’ pay offers – as it happened

RMT general secretary says members could not accept offer he says would make railways less safe

The Guardian - UK

Take AstraZeneca’s warning seriously. The UK is missing out in life sciences

Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain

The Guardian - UK

End of vaccine boost for AstraZeneca as it looks elsewhere for growth

The firm made just shy of $4 billion from sales of its Covid-19 vaccine in 2021, but sales have since more than halved and were down 95% at the tail end of last year

Evening Standard

FTSE 100 Live: Unilever price warning, AstraZeneca and BAT post results

Blue-chip companies Unilever, AstraZeneca and British American Tobacco today lead a busy session for end-of-year corporate earnings.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

A technicality could withhold RSV shots

A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine

WEKU

A single-shot treatment to protect infants from RSV may be coming soon

The illness sends tens of thousands of babies to the hospital each year. If approved, the new injection would be the first broadly available prevention tool.

ABC News

Health department reviewing fifth COVID-19 vaccine. But what if you have missed a dose?

The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.

ABC News

ATAGI is considering a fifth COVID-19 vaccine dose, but how many boosters should I already have and who is eligible?

The federal government is waiting on advice about whether Australians should have a fifth COVID-19 vaccine. So, how many people have had the current boosters and who is eligible for what?

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

How anti-vaccine misinformation hampers conversation about genuine concerns

With more than 13 billion doses administered to date, we know Covid vaccines are overwhelmingly safe, effective,

The Conversation

Andrew Bridgen: how anti-vaccine misinformation hampers the conversation about genuine vaccine injuries

MP Andrew Bridgen was suspended from the Conservative party on January 11 for persistent misinformation about COVID vaccines, including numerous false claims around their safety. The final straw appears to have been his comments comparing the vaccination programme to the Holocaust.

Bangkok Post

Gradual arrival of Chinese expected, no Covid test, says Anutin

Public Health Minister Anutin Charnvirakul does not expect a sudden influx of Chinese tourists or see a need for any special arrival rules for them.

The Conversation

How common are severe side effects from COVID vaccines? And how are they detected?

Former federal MP Dr Kerryn Phelps has talked this week about the medical problems she and her wife had after their COVID-19 vaccinations around 18 months ago.

Bangkok Post

Korean jab maker scouts Asean links

SEOUL: A South Korean company is looking for a business opportunity with partners from the Association of Southeast Asian Nations (Asean) to help develop the regional market for its Covid-19 vaccine.

The Independent UK

Covid vaccine concerns were overblown, says AstraZeneca boss as he is knighted

Sir Pascal Soriot was speaking after he was knighted by the King at Windsor Castle on Wednesday.

The Independent UK

Scientists hail ‘landmark moment’ in the treatment of advanced breast cancer

Capivasertib is being made by pharmaceutical giant AstraZeneca following a programme of drug discovery research at the Institute of Cancer Research.

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.